United Statesmorganstanley.com
Morgan Stanley & Co. LLC is the primary U.S. broker-dealer subsidiary of Morgan Stanley, a global financial services firm headquartered at 1585 Broadway, New York, NY. Established in 1969 and regulated by the SEC and FINRA, it provides a wide range of investment banking, capital markets, wealth management, research, trading, and financial advisory services to clients worldwide.
As a leading investment bank, it advises on mergers and acquisitions, capital raising, equities valuations, and recapitalizations across various sectors, including pharmaceuticals and biotech as seen in its role as financial advisor to Eli Lilly in the acquisition of Centessa Pharmaceuticals.
Also known as MS & Co. LLC.
All-stock merger creates an integrated North American chemicals platform with vertical chlorine/caustic integration, ~$12.5B pro forma revenue and $400M+ identified synergies.
$38/ADS cash + up to $9 CVR (max $47/sh); upfront equity ~$6.3B (CVR ~$1.5B). Lead OX2R agonist cleminorexton showed positive Phase 2a for narcolepsy and idiopathic hypersomnia. Close expected Q3
